Showing results (111-120 of 2,397) with videos related to
Sort By:
Pageof 240
Translational Lung Cancer Research|March 21, 2025
Lung cancer organoids: a new strategy for precision medicine researchYuan Meng, Xinyi Shu, Jie Yang, et al.Translational Lung Cancer Research|March 21, 2025
Clinical-genomic nomogram for predicting sensitivity to second-line immunotherapy for advanced non-small cell lung cancerYing Hua, Ai Wang, Chao Xie, et al.Translational Lung Cancer Research|March 21, 2025
Risk factors for postoperative pulmonary complications in non-adenocarcinoma non-small cell lung cancer patients undergoing surgery after neoadjuvant therapyHu Zhang, Xiaowei Mao, Jingwei Xu, et al.Translational Lung Cancer Research|March 21, 2025
Whole-section digital analysis of immune profiles in surgically resected small cell lung carcinoma and their associations with molecular subtypesYanli Zhu, Jianghua Wu, Haiyue Wang, et al.Translational Lung Cancer Research|March 21, 2025
Predictive value of perioperative carcinoembryonic antigen changes for recurrence in non-small cell lung cancerHua Sun, Sikai Wu, Zhongxiao Chen, et al.Translational Lung Cancer Research|March 21, 2025
Aspirin impedes non-small cell lung cancer development via fine-tuning the CD36 localization regulated by GPIHBP1Wei Liu, Dujuan Qiao, Jia Chen, et al.Translational Lung Cancer Research|March 21, 2025
Real-world comparison of neoadjuvant pembrolizumab plus chemotherapy versus tislelizumab plus chemotherapy in patients with resectable non-small cell lung cancer: a retrospective cohort study of treatment outcomesYan Hu, Siying Ren, Juan Feng, et al.Translational Lung Cancer Research|November 9, 2017
Classification of pulmonary neuroendocrine tumors: new insightsGiuseppe Pelosi, Angelica Sonzogni, Sergio Harari, et al.Translational Lung Cancer Research|March 15, 2018
Tumor heterogeneity in small cell lung cancer defined and investigated in pre-clinical mouse modelsYan Ting Shue, Jing Shan Lim, Julien SageTranslational Lung Cancer Research|December 4, 2018
Clinical utility of tumor mutational burden in patients with non-small cell lung cancer treated with immunotherapyLizza E Hendriks, Etienne Rouleau, Benjamin BessePageof 240